Are you living with Crohn’s Disease and looking for new treatment options? You may qualify to participate in a clinical study evaluating a new medication designed to reduce inflammation in the colon and help manage Crohn’s symptoms.

Eligibility: 

• Adults 18 to 80 years old
• Confirmed diagnosis of Crohn’s Disease for at least 3 months
• History of a lack of response or intolerance to prior Crohn’s treatments (e.g., biologics, immunosuppressants, corticosteroids)
• Able to comply with study visits and procedures

Fill out our form to see if you qualify today!